Enhanced Cancer Vaccination by In Situ Nanomicelle-Generating Dissolving Microneedles

ACS Nano
Nak Won KimJi Hoon Jeong

Abstract

Efficient delivery of tumor antigens and immunostimulatory adjuvants into lymph nodes is crucial for the maturation and activation of antigen-presenting cells (APCs), which subsequently induce adaptive antitumor immunity. A dissolving microneedle (MN) has been considered as an attractive method for transcutaneous immunization due to its superior ability to deliver vaccines through the stratum corneum in a minimally invasive manner. However, because dissolving MNs are mostly prepared using water-soluble sugars or polymers for their rapid dissolution in intradermal fluid after administration, they are often difficult to formulate with poorly water-soluble vaccine components. Here, we develop amphiphilic triblock copolymer-based dissolving MNs in situ that generate nanomicelles (NMCs) upon their dissolution after cutaneous application, which facilitate the efficient encapsulation of poorly water-soluble Toll-like receptor 7/8 agonist (R848) and the delivery of hydrophilic antigens. The sizes of NMCs range from 30 to 40 nm, which is suitable for the efficient delivery of R848 and antigens to lymph nodes and promotion of cellular uptake by APCs, minimizing systemic exposure of the R848. Application of MNs containing tumor model anti...Continue Reading

References

Aug 4, 1998·Journal of Pharmaceutical Sciences·S HenryM R Prausnitz
Feb 13, 2001·Anesthesia and Analgesia·S KaushikM R Prausnitz
Mar 1, 2002·Current Opinion in Immunology·Olivera J Finn, Guido Forni
Dec 9, 2003·Nature Biotechnology·Sungjee KimJohn V Frangioni
Mar 17, 2004·Advanced Drug Delivery Reviews·Mark R Prausnitz
Jan 22, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Keith B GordenJohn P Vasilakos
Feb 12, 2008·Biomaterials·Jeong W LeeMark R Prausnitz
Aug 15, 2008·The Oncologist·Evelien L J M SmitsViggo F I Van Tendeloo
May 19, 2009·Cancer Immunology, Immunotherapy : CII·Evelien L J M SmitsViggo F I Van Tendeloo
Mar 17, 2010·Molecular Pharmaceutics·Eric M BachelderAndrea M Keane-Myers
Jul 20, 2010·Nature Medicine·Sean P SullivanMark R Prausnitz
Feb 26, 2011·Annals of the Rheumatic Diseases·Sergei I Grivennikov, Michael Karin
May 7, 2013·International Journal of Pharmaceutics·Ryan F DonnellyA David Woolfson
Jun 8, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Jung Dong KimHyungil Jung
Jul 17, 2013·Langmuir : the ACS Journal of Surfaces and Colloids·Abhinav Maheswaran Pragatheeswaran, Shing Bor Chen
Sep 17, 2013·Drug Design, Development and Therapy·Xiaoyun HongWeien Yuan
Jan 1, 2011·Cancers·Sylvia Lee, Kim Margolin
Jan 28, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Nak Won KimJi Hoon Jeong
Feb 22, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Maelíosa T C McCruddenRyan F Donnelly
Jul 16, 2014·Expert Opinion on Drug Delivery·Helen L QuinnRyan F Donnelly
Jul 15, 2015·Chemical Reviews·Darrell J IrvineTalar Tokatlian
Aug 26, 2015·Nature Reviews. Clinical Oncology·David Killock
Feb 22, 2017·Journal of Controlled Release : Official Journal of the Controlled Release Society·Guojun Ma, Chengwei Wu
May 10, 2017·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Eva M Vicente-PerezRyan F Donnelly
Nov 21, 2017·Journal of Controlled Release : Official Journal of the Controlled Release Society·Huu Thuy Trang DuongDoo Sung Lee
Mar 2, 2018·Journal of Biomedical Nanotechnology·Ying HaoZhiYong Qian

❮ Previous
Next ❯

Citations

Dec 19, 2019·Journal of Drug Targeting·Morteza RabieiSteven J P McInnes
Jan 21, 2020·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Huu Thuy Trang DuongDoo Sung Lee
Jul 16, 2020·Human Vaccines & Immunotherapeutics·Thuy Trang NguyenJung-Hwan Park
Mar 4, 2020·Acta Pharmacologica Sinica·Fan YangZhi-Yong Qian
May 23, 2020·Bioengineering & Translational Medicine·Sharon W T ChewChenjie Xu
Aug 28, 2020·Frontiers in Bioengineering and Biotechnology·Luis Abelardo Villarruel MendozaPaolo Nicolas Catalano
Mar 1, 2019·Advanced Biosystems·Junyu CaiYaping Li
Dec 15, 2020·Expert Review of Vaccines·Mohammad Zaki AhmadSohail Akhter
Sep 3, 2019·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·André F MoreiraIlídio J Correia
Oct 24, 2019·Journal of Controlled Release : Official Journal of the Controlled Release Society·Parbeen SinghXu Zhang
Dec 20, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Hamed AmaniHélder A Santos
Mar 5, 2021·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Qian LiDongming Xing
Sep 4, 2020·Expert Opinion on Drug Delivery·Lindsay BarnumAli Tamayol
Feb 25, 2021·Research : a Science Partner Journal·Xiaoxuan ZhangYuanjin Zhao
Jul 7, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Minglong ChenChuanbin Wu
Nov 7, 2020·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Thuy Trang NguyenVan Giau Vo
May 14, 2021·Journal of Controlled Release : Official Journal of the Controlled Release Society·Defu ZhiRyan F Donnelly
May 30, 2021·Advanced Materials·DaeYong LeeBetty Y S Kim
Jul 27, 2021·Journal of Controlled Release : Official Journal of the Controlled Release Society·Xiao HeXuli Feng
Sep 12, 2020·Chemical Reviews·Wen-Hao Li, Yan-Mei Li
Oct 14, 2019·ACS Biomaterials Science & Engineering·Hyemin KimSei Kwang Hahn
Jan 20, 2021·ACS Biomaterials Science & Engineering·Gao SongYuhui Yang
Oct 16, 2021·Advanced Materials·Jing LiuKanyi Pu
Nov 10, 2021·Biomaterials Science·Shuyao RuanNianping Feng

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.